Clinical study of columnar balloon dilatation therapy for severe dysphagia caused by upper esophageal sphincter achalasia after stroke

Q4 Medicine
Wei-bo Shao, Yaofei Wang, Wei Jiang, L. Tian, Jiehong Zhang
{"title":"Clinical study of columnar balloon dilatation therapy for severe dysphagia caused by upper esophageal sphincter achalasia after stroke","authors":"Wei-bo Shao, Yaofei Wang, Wei Jiang, L. Tian, Jiehong Zhang","doi":"10.3969/CJCNN.V17I3.1561","DOIUrl":null,"url":null,"abstract":"Objective To investigate the mechanism and effect of columnar balloon dilatation therapy on treating patients with severe dysphagia caused by upper esophageal sphincter (UES) achalasia after stroke. Methods Sixty -four patients with severe dysphagia caused by UES achalasia after stroke were diagnosed through Video Fluoroscopic Swallowing Study (VFSS) and esophageal dynamics testing. The patients were randomly divided into control group (N = 32) and treatment group (N = 32). Patients in control group were treated with routine drug treatment and routine rehabilitation training, while patients in treatment group were treated with columnar balloon dilatation therapy on the basis of routine treatment. The treatment end point was either the patient resuming an oral diet or after 4-weeks treatment. All cases were evaluated by swallowing function of VFSS, high resolution manometry (HRM) and scores of the severity of dysphagia before treatment and at treatment end point. Results Compared with before treatment, UES resting pressure ( P = 0.000) and residual pressure ( P = 0.000) were significantly decreased, peak pressure was significantly increased ( P = 0.000), duration of relaxation was prolonged ( P = 0.000), and scores of the severity of dysphagia were significantly increased ( P = 0.000, 0.000) in both groups after treatment. Compared with control group, UES resting pressure ( P = 0.001) and residual pressure ( P = 0.000) were significantly decreased, peak pressure was significantly increased ( P = 0.002), duration of relaxation was prolonged ( P = 0.000), and scores of the severity of dysphagia were significantly increased ( P = 0.000) in treatment group after treatment. Until the treatment end point or after 4-week treatment, the total effective rate in treatment group was significantly higher than that in control group [93.75% (30/32) vs. 81.25% (26/32); χ 2 = 4.010, P = 0.000]. Conclusions Columnar balloon dilatation therapy is effective for reducing the tension of upper esophageal sphincter and relieving spasm after stroke. It has obvious therapeutic effect on the upper esophageal sphincter achalasia. DOI: 10.3969/j.issn.1672-6731.2017.03.005","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"185-191"},"PeriodicalIF":0.0000,"publicationDate":"2017-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国现代神经疾病杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3969/CJCNN.V17I3.1561","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Objective To investigate the mechanism and effect of columnar balloon dilatation therapy on treating patients with severe dysphagia caused by upper esophageal sphincter (UES) achalasia after stroke. Methods Sixty -four patients with severe dysphagia caused by UES achalasia after stroke were diagnosed through Video Fluoroscopic Swallowing Study (VFSS) and esophageal dynamics testing. The patients were randomly divided into control group (N = 32) and treatment group (N = 32). Patients in control group were treated with routine drug treatment and routine rehabilitation training, while patients in treatment group were treated with columnar balloon dilatation therapy on the basis of routine treatment. The treatment end point was either the patient resuming an oral diet or after 4-weeks treatment. All cases were evaluated by swallowing function of VFSS, high resolution manometry (HRM) and scores of the severity of dysphagia before treatment and at treatment end point. Results Compared with before treatment, UES resting pressure ( P = 0.000) and residual pressure ( P = 0.000) were significantly decreased, peak pressure was significantly increased ( P = 0.000), duration of relaxation was prolonged ( P = 0.000), and scores of the severity of dysphagia were significantly increased ( P = 0.000, 0.000) in both groups after treatment. Compared with control group, UES resting pressure ( P = 0.001) and residual pressure ( P = 0.000) were significantly decreased, peak pressure was significantly increased ( P = 0.002), duration of relaxation was prolonged ( P = 0.000), and scores of the severity of dysphagia were significantly increased ( P = 0.000) in treatment group after treatment. Until the treatment end point or after 4-week treatment, the total effective rate in treatment group was significantly higher than that in control group [93.75% (30/32) vs. 81.25% (26/32); χ 2 = 4.010, P = 0.000]. Conclusions Columnar balloon dilatation therapy is effective for reducing the tension of upper esophageal sphincter and relieving spasm after stroke. It has obvious therapeutic effect on the upper esophageal sphincter achalasia. DOI: 10.3969/j.issn.1672-6731.2017.03.005
柱状球囊扩张治疗脑卒中后上食管括约肌失弛缓症引起的严重吞咽困难的临床研究
目的探讨柱状球囊扩张治疗脑卒中后上食管括约肌失弛缓症引起的严重吞咽困难的机制及疗效。方法对64例脑卒中后UES贲门失弛缓症引起的严重吞咽困难患者,通过视频荧光镜吞咽研究(VFSS)和食管动力学测试进行诊断。将患者随机分为对照组(N=32)和治疗组(N=32)。对照组采用常规药物治疗和常规康复训练,治疗组在常规治疗的基础上采用柱状球囊扩张治疗。治疗终点是患者恢复口服饮食或治疗4周后。所有病例在治疗前和治疗结束时通过VFSS的吞咽功能、高分辨率测压(HRM)和吞咽困难严重程度评分进行评估。结果与治疗前相比,两组治疗后UES静息压(P=0.000)和残余压(P=0.0000)均显著降低,峰值压显著升高(P=0.000。与对照组相比,治疗组治疗后UES静息压(P=0.001)和残余压(P=0.000)显著降低,峰值压显著升高(P=0.002),放松时间延长(P=0.0000),吞咽困难严重程度评分显著升高(P=0.000)。直至治疗结束或治疗4周后,治疗组总有效率明显高于对照组[93.75%(30/32)vs.81.25%(26/32);χ2=4.010,P=0.000]。对食管上括约肌失弛缓症有明显的治疗作用。DOI:10.3969/j.issn.1672-6731017.03.005
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
中国现代神经疾病杂志
中国现代神经疾病杂志 Medicine-Neurology (clinical)
CiteScore
0.40
自引率
0.00%
发文量
4914
审稿时长
10 weeks
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信